Sanofi Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5,966	7,657	7,441	8,710	12,736	10,098
Trading Asset Securities	-	17	115	112	146	11
Cash & Short-Term Investments	5,966	7,674	7,556	8,822	12,882	10,109
Cash Growth	-33.01%	1.56%	-14.35%	-31.52%	27.43%	-27.35%
Accounts Receivable	-	8,410	7,677	8,433	8,424	7,568
Other Receivables	326	2,636	2,952	2,607	2,323	2,219
Receivables	326	11,046	10,629	11,040	10,747	9,787
Inventory	25,023	10,214	9,431	9,666	8,960	8,715
Prepaid Expenses	-	918	895	768	714	615
Other Current Assets	1,892	1,100	14,077	374	808	1,427
Total Current Assets	33,207	30,952	42,588	30,670	34,111	30,653
Property, Plant & Equipment	12,076	11,511	11,601	11,814	11,684	11,976
Long-Term Investments	-	6,854	3,259	2,666	2,765	2,422
Goodwill	-	41,300	43,384	49,404	49,892	48,056
Other Intangible Assets	67,626	17,530	14,260	18,281	15,414	13,677
Long-Term Deferred Tax Assets	-	8,608	7,967	6,427	5,381	4,598
Long-Term Deferred Charges	-	8,731	8,369	6,038	6,226	7,730
Other Long-Term Assets	17,378	926	868	573	797	645
Total Assets	130,287	126,805	132,798	126,464	126,722	120,242

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	24,553	7,361	7,551	7,328	6,813	6,180
Accrued Expenses	-	2,467	2,366	2,501	2,578	2,554
Short-Term Debt	3,349	240	200	203	164	189
Current Portion of Long-Term Debt	-	4,102	4,016	1,843	4,010	2,995
Current Portion of Leases	216	272	261	275	277	269
Current Income Taxes Payable	1,429	751	697	597	574	309
Current Unearned Revenue	-	-	-	-	269	321
Other Current Liabilities	220	13,152	14,071	11,460	9,289	8,478
Total Current Liabilities	29,767	28,345	29,162	24,207	23,974	21,295
Long-Term Debt	14,593	14,329	11,791	14,347	14,857	17,123
Long-Term Leases	1,687	1,467	1,645	1,755	1,904	1,839
Pension & Post-Retirement Benefits	-	1,441	1,992	2,214	2,039	2,947
Long-Term Deferred Tax Liabilities	1,573	1,666	2,166	1,857	1,841	1,617
Other Long-Term Liabilities	9,426	7,847	8,185	7,731	6,955	6,390
Total Liabilities	57,046	55,095	54,941	52,111	51,570	51,211

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	72,879	2,439	2,526	2,530	2,522	2,527
Additional Paid-In Capital	-	1	-	313	125	532
Treasury Stock	-	-1,072	-840	-1,184	-706	-939
Comprehensive Income & Other	-	70,008	75,821	72,381	72,843	66,561
Total Common Equity	72,879	71,376	77,507	74,040	74,784	68,681
Minority Interest	362	334	350	313	368	350
Shareholders' Equity	73,241	71,710	77,857	74,353	75,152	69,031
Total Liabilities & Equity	130,287	126,805	132,798	126,464	126,722	120,242

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	19,845	20,410	17,913	18,423	21,212	22,415
Net Cash (Debt)	-13,879	-12,736	-10,357	-9,601	-8,330	-12,306
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-11.48	-10.39	-8.25	-7.64	-6.63	-9.78
Filing Date Shares Outstanding	1,200	1,208	1,254	1,249	1,249	1,249
Total Common Shares Outstanding	1,200	1,208	1,254	1,251	1,253	1,253
Working Capital	3,440	2,607	13,426	6,463	10,137	9,358
Book Value Per Share	60.73	59.10	61.83	59.17	59.70	54.83
Tangible Book Value	5,253	12,546	19,863	6,355	9,478	6,948
Tangible Book Value Per Share	4.38	10.39	15.84	5.08	7.57	5.55
Land	-	149	201	228	237	240
Buildings	-	7,062	7,444	7,681	7,328	7,170
Machinery	-	12,680	12,843	13,412	13,363	14,303
Construction In Progress	-	3,585	3,573	3,449	2,996	3,097

SEC Filings: 10-K · 10-Q